Receive the weekly sampler of posts and "Resource of the Week".
Subscribe »

Enter your
email address:

My Account »


Bookmark and Share

Testimonial?
If you find ResourceShelf useful, please supply a testimonial »








Home > ResourceBlog > Article

« All ResourceBlog Articles

 

Bookmark and Share   Feed

Saturday, 27th September 2008

Did the study work? Consumers can find out

Did the study work? Consumers can find out

Many of the most promising new medical treatments are just beyond the grasp of consumers simply because they don't know about them. But that's about to change. Beginning tomorrow, the nation's database for clinical trials, www.ClinicalTrials.com, will begin adding the results of trials of drugs, medical devices and biologic products (such as vaccines) conducted in the United States.

ClinicalTrials.com was launched in 2000 to provide people with easy access to information about clinical trials. But until now, consumers who went to the website could find only details about the trial's launch, such as the study's design and who is eligible to enroll. Under the new rule, researchers sponsoring the trial must go back and post their results (except for very early-stage experiments, which are called Phase 1 trials) online within one year of the study's conclusion or within 30 days of approval of a product by the Food and Drug Administration. The database will carry results of trials that were underway as of Sept. 27, 2007. However, researchers of previously completed trials have been encouraged to post their results, too.

The rule is a result of a law passed last year to demand more transparency in clinical trials. Consumer health advocates hope the requirement will make it harder for study sponsors to hide unexpected or harmful reactions to drugs or devices. In the past, consumers could only turn to medical and scientific journals to find out a study's results. If the study wasn't published, which sometimes happens especially if the trial failed, no one knew. Some pharmaceutical companies have been accused of hiding the results of studies, such as the side effects that were discovered with the arthritis medication Vioxx that was removed from the market in 2004.

Source: Booster Shots (Los Angeles Times)


Category:

Views: 744




blog comments powered by Disqus

« All ResourceBlog Articles

 

Read about the FreePint FamilyFreePint Family

A family of resources to help information workers be more effective, raise the value of information in their organisations and contribute to success. Read more »


FeedLatest Family Articles:


Click to view the article Quilting big data threads
Thursday, 24th May 2012

Recently I have found myself cooing over visualisation maps (and heat maps) of health and well being resources. The content rich data is overlayed with mapping technologies, and some interesting themes and patterns are emerging.


Click to view the article The fallacy of information overload
Wednesday, 23rd May 2012

A lot of the talk around social media in the last year has been around information overload. Social media has provided us with new and exciting ways to create content. But it has also meant learning new ways to manage and engage with social media tools. Are we teetering on the edge of an information overload precipice?


Click to view the article Information overload: fact, fantasy or filter failure?
Wednesday, 23rd May 2012

Information overload is a figment of your imagination. Or a failure of your filter. Or a symptom of your technological submissiveness. Depends on who you ask.


Click to view the article Newsdesk: tracking millions of pieces of information a day
Tuesday, 22nd May 2012

What if you had to sort through 3.5 million articles and social media posts a day and try to pull out the most relevant items for your organisation? What if you then had to cobble it all together into something readable for your top groups and executives in your organisation?


Click to view the article Alacra Compliance adds managerial oversight
Tuesday, 22nd May 2012

Alacra Compliance saves time by aggregating information from both free and fee-based sources and enabling users to conduct an accurate federated search across these sources (coined “simultaneous search” by Alacra).


All Family Articles »
Family Articles by Category »


Tell us what you're working on,
and we'll talk to you about how FreePint can help »


FreePint Family Testimonials

"Fabulous resource to learn of unique tools and insights. Very useful." Manager, Futures and Forecasting, Virginia, USA

More testimonials »






Subscribe

Subscribe to the ResourceShelf Newsletter and receive the weekly sampler of posts and Resource of the Week.

Find out more »

ResourceShelf sponsored by:

Article Categories

All Article Categories »

Archive

All Archives »